IndustryPayments

ADAM PRICE

CHARLESTON, SC

Browse related groups: SC Retrophin, Inc. All categories

This page merges CMS profile IDs: 5702090, 8800512 (associated profiles published by CMS for the same provider; see the provenance section below).

General Payments — all program years on this page

$2,976.98

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 135
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,152.11 across 51 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $923.6648
Consulting Fee $225.001
Education $3.452

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Retrophin, Inc. $313.428
Acerta Pharma LLC $210.329
OPKO Pharmaceuticals, LLC $181.0213
Otsuka America Pharmaceutical, Inc. $91.954
CALLIDITAS THERAPEUTICS US INC. $83.763
Mallinckrodt Hospital Products Inc. $61.562
Bayer HealthCare Pharmaceuticals Inc. $56.383
Amgen Inc. $39.892
Novo Nordisk AS $29.702
GENZYME CORPORATION $20.951
Relypsa, Inc. $16.891
GlaxoSmithKline, LLC. $16.411
Lilly USA, LLC $15.021
Boehringer Ingelheim Pharmaceuticals, Inc. $14.841

By program year

Program yearAmountRecords
2018 $76.571
2020 $196.362
2021 $287.008
2022 $712.5139
2023 $552.4334
2024 $1,152.1151

Records — PY2024 (51)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086130826 Bayer Healthcare Pharmaceuticals Inc. $18.17 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086171514 Bayer Healthcare Pharmaceuticals Inc. $17.08 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086201610 Bayer Healthcare Pharmaceuticals Inc. $21.13 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096887426 Novo Nordisk Inc $16.07 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097251811 Novo Nordisk Inc $13.63 04/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104212187 AstraZeneca Pharmaceuticals LP $20.00 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104403631 AstraZeneca Pharmaceuticals LP $21.90 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104582148 AstraZeneca Pharmaceuticals LP $26.36 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105204293 AstraZeneca Pharmaceuticals LP $26.72 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105366509 AstraZeneca Pharmaceuticals LP $26.78 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105386655 AstraZeneca Pharmaceuticals LP $16.71 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105518463 AstraZeneca Pharmaceuticals LP $22.53 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105543825 AstraZeneca Pharmaceuticals LP $24.95 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105808742 AstraZeneca Pharmaceuticals LP $24.37 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111679762 Amgen Inc. $22.22 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112848526 OPKO Pharmaceuticals, LLC $15.27 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112848528 OPKO Pharmaceuticals, LLC $2.74 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112848530 OPKO Pharmaceuticals, LLC $15.68 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112848532 OPKO Pharmaceuticals, LLC $12.25 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112848534 OPKO Pharmaceuticals, LLC $6.53 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112848536 OPKO Pharmaceuticals, LLC $14.84 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112848538 OPKO Pharmaceuticals, LLC $12.99 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112848540 OPKO Pharmaceuticals, LLC $16.59 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112848542 OPKO Pharmaceuticals, LLC $14.57 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112848544 OPKO Pharmaceuticals, LLC $17.93 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112848546 OPKO Pharmaceuticals, LLC $18.60 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112848548 OPKO Pharmaceuticals, LLC $17.71 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112848550 OPKO Pharmaceuticals, LLC $15.32 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116060613 GlaxoSmithKline, LLC. $16.41 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117357312 Amgen Inc. $17.67 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118237400 Boehringer Ingelheim Pharmaceuticals, Inc. $14.84 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118963637 Otsuka America Pharmaceutical, Inc. $20.26 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118963639 Otsuka America Pharmaceutical, Inc. $24.30 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118963641 Otsuka America Pharmaceutical, Inc. $18.83 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118963643 Otsuka America Pharmaceutical, Inc. $28.56 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124061382 Vifor Pharma, Inc. $16.89 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136010381 Lilly USA, LLC $15.02 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139917941 GENZYME CORPORATION $20.95 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141518257 CALLIDITAS THERAPEUTICS US INC. $31.37 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141525838 CALLIDITAS THERAPEUTICS US INC. $26.71 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141528841 CALLIDITAS THERAPEUTICS US INC. $25.68 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145122111 Mallinckrodt Hospital Products Inc. $27.69 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145122115 Mallinckrodt Hospital Products Inc. $33.87 12/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149906291 Travere Therapeutics, Inc. $0.37 08/05/2024 Education Undisputed 01/23/2026 View at CMS
1149906295 Travere Therapeutics, Inc. $3.08 09/30/2024 Education Undisputed 01/23/2026 View at CMS
1149906299 Travere Therapeutics, Inc. $15.22 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149906303 Travere Therapeutics, Inc. $15.22 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149906306 Travere Therapeutics, Inc. $16.02 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149906310 Travere Therapeutics, Inc. $18.78 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149906314 Travere Therapeutics, Inc. $19.73 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149906318 Travere Therapeutics, Inc. $225.00 10/04/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
  • Merged CMS profile IDs: 5702090, 8800512

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.